Enzo Biochem Liabilities 2025

Enzo Biochem Aktienanalyse

What does Enzo Biochem do?

Enzo Biochem Inc is a US-based company operating in the biotechnology sector. It was founded in 1976 by Elazar Rabbani and is headquartered in New York. The company focuses on developing, producing, and marketing innovative diagnostic and therapeutic products for the medical industry. Enzo Biochem Inc's business model is based on the application of modern technologies for the development and synthesis of molecules for medical technology and life sciences. At the same time, the company also offers diagnostic testing systems and clinical laboratory services to its customers. Enzo Biochem's business model is therefore diverse and covers various areas. Enzo Biochem divides its business into three main segments: life sciences, clinical labs, and therapeutics. In the life sciences segment, the company engages in research and development of technologies for synthesizing molecules for medical technology. In the clinical labs segment, Enzo Biochem offers diagnostic testing systems and clinical laboratory services for use in medical diagnostics. The therapeutics segment manufactures therapeutic products for the treatment of viral infections. Enzo Biochem's product offering includes a wide range of products and services. This includes molecules for medical technology, diagnostic testing systems, and therapy products for viral infections. The product lines of Enzo Biochem include: - Molecules for medical technology: Enzo Biochem has developed a wide range of molecules for medical technology and is a leader in this field. These molecules include proteins, antibodies, and other biomolecules. The company also offers custom molecules for specific applications. - Diagnostic testing systems: The company offers a wide range of diagnostic testing systems tailored to the needs of laboratories and clinics. The tests include tests for infectious diseases, cancer, metabolic disorders, and other diseases. - Clinical laboratory services: Enzo Biochem provides a wide range of clinical laboratory services, including blood tests, microbiological tests, urine, stool, and body fluid tests, as well as histological analysis of tissue samples. - Therapy products: Enzo Biochem has developed a broad portfolio of therapy products for the treatment of viral infections. These products include immunomodulators, antivirals, and other therapeutics aimed at combating various pathogens. Enzo Biochem has made a name for itself in the biotechnology industry through continuous innovation and high-quality products. The company has also engaged in partnerships, acquisitions, and joint ventures to expand its global footprint. It has a global presence and works with leading pharmaceutical and biotech companies from around the world. Overall, Enzo Biochem has established itself as a leading biotechnology company operating in the fields of life sciences, clinical labs, and therapeutics. The company offers a wide range of products and services tailored to the needs of laboratories and clinics. Enzo Biochem has established itself as an innovation leader in the biotechnology industry and is committed to further expanding its business through the development of new products and technologies. Enzo Biochem ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Liabilities Details

Assessing Enzo Biochem's Liabilities

Enzo Biochem's liabilities constitute the company's financial obligations and debts owed to external parties and stakeholders. They are categorized into current liabilities, due within a year, and long-term liabilities, which are due over a longer period. A detailed assessment of these liabilities is crucial for evaluating Enzo Biochem's financial stability, operational efficiency, and long-term viability.

Year-to-Year Comparison

By comparing Enzo Biochem's liabilities year-over-year, investors can identify trends, shifts, and anomalies in the company’s financial positioning. A decrease in total liabilities often signals financial strengthening, while an increase might indicate enhanced investments, acquisitions, or potential financial strain.

Impact on Investments

Enzo Biochem's total liabilities play a significant role in determining the company's leverage and risk profile. Investors and analysts examine this aspect meticulously to ascertain the firm’s ability to meet its financial obligations, which influences investment attractiveness and credit ratings.

Interpreting Liability Fluctuations

Shifts in Enzo Biochem’s liability structure indicate changes in its financial management and strategy. A reduction in liabilities reflects efficient financial management or debt payoffs, while an increase may suggest expansion, acquisition activities, or accruing operational expenses, each carrying distinct implications for investors.

Frequently Asked Questions about Enzo Biochem stock

What is the level of liabilities of Enzo Biochem this year?

Enzo Biochem has a debt balance of 29.65 M USD this year.

What were the liabilities of Enzo Biochem compared to the previous year?

The liabilities of Enzo Biochem have increased by -31.71% dropped compared to the previous year.

What are the consequences of high debt for investors of Enzo Biochem?

High liabilities can pose a risk for investors of Enzo Biochem, as they can weaken the company's financial position and impair its ability to meet its obligations.

What consequences do low liabilities have for investors in Enzo Biochem?

Low liabilities mean that Enzo Biochem has a strong financial position and is able to meet its obligations without overburdening its finances.

How does an increase in liabilities of Enzo Biochem affect the company?

An increase in liabilities of Enzo Biochem can lead to the company having more obligations and potentially find it more difficult to meet its financial commitments.

How does a reduction in the liabilities of Enzo Biochem affect the company?

A decrease in the liabilities of Enzo Biochem can lead to the company having fewer obligations and a stronger financial position, which can make it easier for the company to fulfill its financial commitments.

What are some factors that influence the liabilities of Enzo Biochem?

Some factors that can influence the liabilities of Enzo Biochem include investments, acquisitions, operating costs, and sales development.

Why is the level of liabilities of Enzo Biochem so important for investors?

The liabilities of Enzo Biochem are important for investors as they serve as an indicator of the company's financial stability and provide investors with information on how the company meets its financial obligations.

What strategic measures can Enzo Biochem take to modify the liabilities?

To change its liabilities, Enzo Biochem can take measures such as cost savings, increasing revenue, selling assets, raising investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to choose the best strategic actions.

How much dividend does Enzo Biochem pay?

Over the past 12 months, Enzo Biochem paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Enzo Biochem is expected to pay a dividend of 0 USD.

What is the dividend yield of Enzo Biochem?

The current dividend yield of Enzo Biochem is .

When does Enzo Biochem pay dividends?

Enzo Biochem pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Enzo Biochem?

Enzo Biochem paid dividends every year for the past 0 years.

What is the dividend of Enzo Biochem?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Enzo Biochem located?

Enzo Biochem is assigned to the 'Health' sector.

Wann musste ich die Aktien von Enzo Biochem kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Enzo Biochem from 12/2/2024 amounting to 0.1 USD, you needed to have the stock in your portfolio before the ex-date on 11/15/2024.

When did Enzo Biochem pay the last dividend?

The last dividend was paid out on 12/2/2024.

What was the dividend of Enzo Biochem in the year 2024?

In the year 2024, Enzo Biochem distributed 0 USD as dividends.

In which currency does Enzo Biochem pay out the dividend?

The dividends of Enzo Biochem are distributed in USD.